Your Location:
Home >
Browse articles >
Notoginseng Radix et Rhizoma Powder Treats Dyslipidemia via PI3K/Akt Signaling Pathway
Notoginseng Radix et Rhizoma Powder Treats Dyslipidemia via PI3K/Akt Signaling Pathway
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 29, Issue 13, Pages: 88-95(2023)
DOI: 10.13422/j.cnki.syfjx.20232290
Scan QR Code
Full Text(HTML)
Figs( 0 ) Tabs( 7 )
References
Publication Info
Metrics
245
Views
143
Downloads
7
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Clinical Study on Treatment of Non-alcoholic Steatohepatitis Patients with Dyslipidemia by Dizhuo Huayu Prescription with Catgut Embedding Therapy
Evaluation of GRADE Clinical Research Evidence of Chinese Patent Medicine Combined with Western Medicine in Treatment of Hypertension with Dyslipidemia
Effect of Guben Jiedu Prescription-medicated Serum on Epithelial-mesenchymal Transition of Lung Cancer A549 Cells: Based on PI3K/Akt Signaling Pathway
Oral Chinese Patent Medicines for Hyperlipidemia: A Scoping Review of Clinical Evidence
Effect of Wumeiwan-medicated Serum on Proliferation, Invasion, Migration, Apoptosis of Pancreatic Cancer Cells Based on PI3K/Akt Signaling Pathway
Related Author
ZHAO Wenxia
LIU Xiaoyan
SHANG Dongfang
ZHANG Lihui
ZHAO Chenlu
WANG Siying
CHEN Huaxin
WANG Jiaheng
Related Institution
The First Clinical Medical School, Henan University of Chinese Medicine
The First Affiliated Hospital of Henan University of Chinese Medicine
Dongzhimen Hospital, Beijing University of Chinese Medicine
Shaanxi University of Chinese Medicine
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences


